Related Experiment Video
Updated: Aug 11, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Effects of atorvastatin on higher functions
G P Parale1, N N Baheti, P M Kulkarni
1Department of Medicine, Dr. VM Medical College Solapur, Maharashtra, India.
European Journal of Clinical Pharmacology
|February 21, 2006
Summary
Atorvastatin significantly improved cognitive functions, including attention and memory, in adults over 40. This 10 mg daily dose showed benefits in higher mental functions over a six-month period.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Cognitive decline is a concern in adults, particularly those with cardiovascular conditions.
- Statins, like atorvastatin, are widely used for cardiovascular health.
Purpose of the Study:
- To evaluate the impact of atorvastatin on cognitive functions and higher mental processes.
- To determine if atorvastatin offers cognitive benefits beyond its cardiovascular effects.
Main Methods:
- A before-and-after study with a placebo-controlled group.
- 55 subjects aged 40+ received atorvastatin (10 mg/day); a matched control group received a placebo.
- Cognitive assessments included tests for attention, psychomotor speed, mental flexibility, working memory, and memory retrieval, conducted at baseline and after 6 months.
Main Results:
- Both atorvastatin and placebo groups showed learning effects on cognitive tests.
- The atorvastatin group demonstrated statistically significant improvements across all cognitive domains compared to the placebo group.
- Key improvements were observed in attention, psychomotor speed, mental flexibility, working memory, and memory retrieval.
Conclusions:
- Atorvastatin, at a 10 mg daily dose, significantly enhances higher cognitive functions.
- The study supports the beneficial effects of atorvastatin on neurocognitive performance over a 6-month period.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...